Rankings
▼
Calendar
CTKB Q1 2021 Earnings — Cytek Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
CTKB
Cytek Biosciences, Inc.
$553M
Q1 2021 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$24M
+34.9% YoY
Gross Profit
$14M
59.7% margin
Operating Income
$1M
4.7% margin
Net Income
$102,000
0.4% margin
EPS (Diluted)
$0.00
QoQ Revenue Growth
-20.7%
Cash Flow
Operating Cash Flow
$2M
Free Cash Flow
$1M
Stock-Based Comp.
$456,000
Balance Sheet
Total Assets
$224M
Total Liabilities
$239M
Stockholders' Equity
-$15M
Cash & Equivalents
$169M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$24M
$18M
+34.9%
Gross Profit
$14M
$8M
+73.0%
Operating Income
$1M
-$710,000
+259.4%
Net Income
$102,000
-$839,000
+112.2%
← FY 2021
All Quarters
Q2 2021 →